B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ERKs are inactivated

REACTOME PATHWAY
Reactome: R-HSA-2026705 genes28 compounds

The ERKs are inactivated pathway (Reactome ID: R-HSA-202670) involves 5 genes and is affected by 28 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

DUSP3MAPK1MAPK3MAPK7PPP2CA

Compounds Affecting ERKs are inactivated

#CompoundTargets HitStudies
1plumbagin [Supplementary Concept]300
2pd980597
3alsterpaullone12
4kenpaullone8
5isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from300
6Sorafenib300
7trametinib296
8withaferin300
9tyrphostin ag 14784
10Clotrimazole296
11sp600125117
12fisetin78
13Progesterone299
142-Chloroadenosine 2-Chloroadenosine.300
15Benzalkonium Compounds299
16Calcimycin216
17daph2
18Diphenhydramine14
19ha10044
20Lithocholic Acid300
21Loratadine296
22trequinsin hydrochloride1
23DEAD-box RNA Helicases169
24Thioctic Acid298
25Oleanolic Acid300
26Thioctic Acid300
27Crizotinib298
28Okadaic Acid300

About the ERKs are inactivated Pathway

The ERKs are inactivated pathway is catalogued in Reactome (ID: R-HSA-202670) and involves 5 genes. In the BiohacksAI corpus, 28 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include DUSP3, MAPK1, MAPK3, MAPK7, PPP2CA.